HAX-1 Activators
The class of HAX-1 activators comprises a diverse range of chemicals intricately influencing HAX-1 activity through various signaling pathways. These activators offer valuable insights into the regulatory mechanisms governing HAX-1 function, highlighting the interconnectedness of cellular processes, including apoptosis, NF-κB signaling, cAMP-dependent pathways, and GSK-3β regulation in orchestrating HAX-1 activation. The indirect activation of HAX-1 by these chemicals emphasizes the complexity of the regulatory network governing this protein and unveils avenues for targeted interventions in cellular processes beyond apoptosis.
The activators provide a nuanced understanding of how specific biochemical and cellular pathways are modulated to enhance HAX-1 activity. By unraveling the intricacies of these pathways, we gain valuable knowledge that goes beyond a simplistic view of HAX-1 as solely an anti-apoptotic protein. The involvement of NF-κB signaling, cAMP-dependent pathways, and GSK-3β regulation suggests that HAX-1 plays a role in diverse cellular functions, making it a central player in cellular regulation. This deeper comprehension opens avenues for further exploration of of HAX-1 activators in the context of cellular regulation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Betulinic Acid | 472-15-1 | sc-200132 sc-200132A | 25 mg 100 mg | $117.00 $344.00 | 3 | |
Betulinic Acid, a triterpenoid, indirectly activates HAX-1 by modulating mitochondrial apoptosis pathways. HAX-1 is involved in anti-apoptotic mechanisms, and Betulinic Acid influences the mitochondrial apoptotic cascade, leading to the indirect activation of HAX-1. This highlights the interconnectedness of mitochondrial apoptosis regulation and HAX-1 activity, providing a potential avenue for targeted activation through modulation of apoptosis-related pathways. | ||||||
Honokiol | 35354-74-6 | sc-202653 sc-202653A | 10 mg 25 mg | $118.00 $178.00 | 4 | |
Honokiol, a natural biphenolic compound, indirectly activates HAX-1 by influencing NF-κB signaling pathways. HAX-1 is implicated in NF-κB activation, and Honokiol modulates NF-κB signaling, leading to the indirect activation of HAX-1. This underscores the role of NF-κB signaling in modulating HAX-1 activity, providing a potential avenue for targeted activation through NF-κB pathway modulation. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA, a potent PKC activator, directly activates HAX-1 through the PKC signaling pathway. HAX-1 is known to be phosphorylated by PKC, and the direct activation by PMA emphasizes the role of PKC in modulating HAX-1 activity. This offers a specific strategy for targeted activation through direct PKC-mediated phosphorylation and activation of HAX-1. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187, a calcium ionophore, indirectly activates HAX-1 by modulating calcium-dependent signaling pathways. HAX-1 activity is influenced by calcium levels, and A23187 modulates calcium signaling, leading to the indirect activation of HAX-1. This highlights the role of calcium-dependent signaling in modulating HAX-1 activity, providing a potential avenue for targeted activation through calcium-related pathways. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol, a polyphenol, indirectly activates HAX-1 by influencing SIRT1 pathways. HAX-1 is known to be regulated by SIRT1-dependent deacetylation, and Resveratrol modulates SIRT1 activity, leading to the indirect activation of HAX-1. This underscores the role of SIRT1-dependent deacetylation in modulating HAX-1 activity, providing a potential avenue for targeted activation through SIRT1 pathway modulation. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin, an adenylate cyclase activator, indirectly activates HAX-1 through cAMP-dependent pathways. HAX-1 is influenced by cAMP levels, and Forskolin enhances cAMP production, leading to the indirect activation of HAX-1. This emphasizes the role of cAMP-dependent signaling in modulating HAX-1 activity, providing a potential avenue for targeted activation through cAMP-related pathways. | ||||||
Thymoquinone | 490-91-5 | sc-215986 sc-215986A | 1 g 5 g | $47.00 $133.00 | 21 | |
Thymoquinone, a bioactive component of black seed oil, indirectly activates HAX-1 by modulating mitochondrial apoptosis pathways. HAX-1 is involved in anti-apoptotic mechanisms, and Thymoquinone influences mitochondrial apoptotic cascades, leading to the indirect activation of HAX-1. This highlights the interconnectedness of mitochondrial apoptosis regulation and HAX-1 activity, providing a potential avenue for targeted activation through modulation of apoptosis-related pathways. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A, a protein phosphatase inhibitor, directly activates HAX-1 through the modulation of phosphatase-dependent pathways. HAX-1 activity is known to be regulated by protein phosphatases, and Calyculin A inhibits their activity, leading to the direct activation of HAX-1. This offers a specific strategy for targeted activation through inhibition of phosphatase-mediated regulation of HAX-1. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
BAY 11-7082, an NF-κB inhibitor, indirectly activates HAX-1 by influencing NF-κB signaling pathways. HAX-1 is implicated in NF-κB activation, and BAY 11-7082 modulates NF-κB signaling, leading to the indirect activation of HAX-1. This underscores the role of NF-κB signaling in modulating HAX-1 activity, providing a potential avenue for targeted activation through NF-κB pathway modulation. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride, a GSK-3β inhibitor, indirectly activates HAX-1 by influencing GSK-3β-dependent pathways. HAX-1 is known to be regulated by GSK-3β, and Lithium chloride inhibits GSK-3β, leading to the indirect activation of HAX-1. This highlights the role of GSK-3β-dependent signaling in modulating HAX-1 activity, providing a potential avenue for targeted activation through GSK-3β pathway modulation. | ||||||